Goodwin wins lucrative work on Moderna’s massive IPO


The biotech expects to incur $5 million in legal expenses related to its upcoming offering, significantly more than many other local IPOs.

Previous BofA pledges $60M in stimulus to emerging markets
Next Dayton start-up acquired by private equity firm